Completely clean FDA-industry user fee deal attached to a must-pass government spending bill
With four days left in the fiscal year, FDA-related policy riders approved in both House and Senate committees, at least for now, appear dead, according to the text of a short-term government spending bill unveiled late last night to keep federal agencies open until Dec. 16.
But the absence of riders (both sides previously announced a “practically clean” deal last week) doesn’t mean Democrats are done fighting to add these accelerated approvals and other regulatory reforms for cosmetics, nutritional products and diagnostic tests.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.